Loading data for WEED.TO — first visit, this takes a few seconds.

Canopy Growth Corporation (WEED.TO)

Toronto: WEED.TO · Real-Time Price · USD

1.34

-0.01 (-0.74%)

At close: Sep 04, 2026, 6:43 PM

Alert

The price, the headline numbers and the latest news, in one place.

No data available

Bid	1.34
Market Cap	640M
Revenue (ttm)	294M
Net Income (ttm)	-233M
	2.43
	-0.67
	n/a
	-7.91
P/B (ttm)	0.65
P/S (ttm)	2.18
Earnings Date	Nov 7, 2025

Ask	1.35
Volume	225,623
Avg. Volume (20D)	977,904
Open	1.34
Previous Close	1.35
Day's Range	1.33 - 1.35
52-Week Range	1.18 - 3.28
Analyst	n/a
Price Target	n/a
Dividends	n/a
Ex-Dividend Date	n/a

About WEED.TO

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, suc...

Sector Healthcare

IPO Date Aug 17, 2010

Employees 1,128

Stock Exchange Toronto

Ticker Symbol WEED.TO

Website https://www.canopygrowth.com

Full Company Profile

Financial Performance

In 2026, Canopy Growth's revenue was 284.6M, an increase of 5.8% compared to the previous year's 269M. Earnings were -262.91M, a decrease of -48.34%.

Financial numbers in CAD Financial Statements

Earnings Surprise

Canopy Growth has released their quarterly earnings on Aug 7, 2026:

Revenue of $81.17M misses estimates by $0, with 12.52% YoY growth.
EPS of -0.02 exceeds estimates by 0.01, with 98.48% YoY growth.

Next Earnings Release

Canopy Growth Corporation is scheduled to release its earnings on Nov 7, 2025, before market opens.
Analysts project revenue of ... Upgrade

Why Price Moved

News

2 weeks ago · Zacks

Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell?

Canopy Growth's cannabis business is showing signs of a turnaround, with revenue growth, improving margins and a narrower EBITDA loss fueling its rally.

2 weeks ago · 24/7 Wall St.

Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here’s Why TLRY Is Still Down 47% YTD

Tilray surged Wednesday alongside Canopy Growth and Aurora Cannabis, but one number from 2026 tells a very different story about why today's rally leaves the real problem untouched.